- Home
- ESPR vs CLB Comparison
ESPR vs CLB Comparison
Compare ESPR & CLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- CLB
- Stock Information
- Founded
- ESPR 2008
- CLB 1936
- Country
- ESPR United States
- CLB United States
- Employees
- ESPR N/A
- CLB N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- CLB
- Sector
- ESPR Health Care
- CLB
- Exchange
- ESPR Nasdaq
- CLB Nasdaq
- Market Cap
- ESPR 534.3M
- CLB 482.5M
- IPO Year
- ESPR 2013
- CLB 1995
- Fundamental
- Price
- ESPR $2.97
- CLB $15.94
- Analyst Decision
- ESPR Buy
- CLB Hold
- Analyst Count
- ESPR 6
- CLB 2
- Target Price
- ESPR $6.50
- CLB $12.50
- AVG Volume (30 Days)
- ESPR 7.1M
- CLB 720.9K
- Earning Date
- ESPR 11-06-2025
- CLB 10-22-2025
- Dividend Yield
- ESPR N/A
- CLB 0.25%
- EPS Growth
- ESPR N/A
- CLB 25.86
- EPS
- ESPR N/A
- CLB 0.68
- Revenue
- ESPR $268,125,000.00
- CLB $517,501,999.00
- Revenue This Year
- ESPR $18.83
- CLB N/A
- Revenue Next Year
- ESPR N/A
- CLB $4.31
- P/E Ratio
- ESPR N/A
- CLB $23.44
- Revenue Growth
- ESPR N/A
- CLB N/A
- 52 Week Low
- ESPR $0.69
- CLB $9.72
- 52 Week High
- ESPR $3.94
- CLB $21.83
- Technical
- Relative Strength Index (RSI)
- ESPR 59.21
- CLB 68.74
- Support Level
- ESPR $2.80
- CLB $11.16
- Resistance Level
- ESPR $3.11
- CLB $17.46
- Average True Range (ATR)
- ESPR 0.17
- CLB 0.80
- MACD
- ESPR 0.01
- CLB 0.38
- Stochastic Oscillator
- ESPR 76.47
- CLB 77.61
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.